SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-008477
Filing Date
2022-05-09
Accepted
2022-05-09 16:04:50
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20220509.htm   iXBRL 8-K 64455
2 EX-99.1 alxo-ex99_1.htm EX-99.1 132205
3 GRAPHIC img62044099_0.jpg GRAPHIC 3897
  Complete submission text file 0000950170-22-008477.txt   327616

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxo-20220509_lab.xml EX-101.LAB 13070
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxo-20220509_pre.xml EX-101.PRE 10597
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxo-20220509.xsd EX-101.SCH 2499
8 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20220509_htm.xml XML 4539
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 22904834
SIC: 2834 Pharmaceutical Preparations